Stockreport

Lykos laying off 75% of workforce following FDA rejection of psychedelic drug for PTSD [Seeking Alpha]

Mind Medicine (MindMed) Inc. - Common Shares  (MNMD) 
PDF FDA's decision earlier in August to reject its application for an MDMA-based drug to treat PTSD. In addition, Rick Doblin, the co-founder of the Multidisciplinary Asso [Read more]